10 February 2026
This year, we are delighted to share the voice of Ngo Thu Huong, Vice Director of Polyvac in Vietnam.
Ngo Thu Huong, Vice Director of Polyvac in Vietnam
In this short film, she offers a glimpse into Polyvac’s journey — an organisation with deep roots in national vaccine production and a growing role in shaping the future of regional health security. Through ambition, adaptability, and a strong commitment to learning, Polyvac is building new capabilities in mRNA vaccines and investing in the people who will carry vaccine innovation forward.
“As a doctor, you may save one person at a time. But when you create a vaccine, you can save an entire community.”
This belief has shaped a career dedicated to vaccine research, innovation, and public service.
The video highlights how science, leadership, and collaboration come together to strengthen preparedness and bring life-saving vaccines closer to the communities they are meant to protect.
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.